The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.
Khalil DN, Budhu S, Gasmi B, Zappasodi R, Hirschhorn-Cymerman D, Plitt T, De Henau O, Zamarin D, Holmgaard RB, Murphy JT, Wolchok JD, Merghoub T.
Khalil DN, et al. Among authors: hirschhorn cymerman d.
Adv Cancer Res. 2015;128:1-68. doi: 10.1016/bs.acr.2015.04.010. Epub 2015 Jun 9.
Adv Cancer Res. 2015.
PMID: 26216629
Review.